NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Excellent analysis Thermo but I do have questions pertaining to the your last sentence which reads:

[quoteNorthwest Biotherapeutics Inc. v. Canaccord, et al. is going better than I would have expected. It’s possible the company will receive a large settlement that will minimize dilution][/quote]

1. What makes you believe that the Canaccord et al. law suit is going better than you had expected? Do you have some information or analysis that you are able to share?

2. I was hoping that winning the suit would gross no less than $500M with about let's say $325M (65%) being retained by NWBO and about $175M (35%) going to Cohen-Milstein (if the lawsuit gains are contingency based). A lawsuit gain for NWBO of about $325M or even considerably less should not only minimize dilution but postpone the need to do so for a very long time IMHO.

Are you then perhaps of the opinion that the lawsuit verdict will result in a much more modest gain for the company that may still require some additional dilution(s) within the next few years?